久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19 prnasia
    April 15, 2020
    On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Lianhua Qing
  • Linzess Approved in Japan for Additional Indication americanpharmaceuticalreview
    August 22, 2018
    Astellas Pharma and Ironwood Pharmaceuticals announced approval has been obtained in Japan for the guanylate cyclase-C receptor agonist Linzess Tablets 0.25 mg (linaclotide) for the additional indication of chronic constipation.
PharmaSources Customer Service